InsidersTradesSigma
Track the Shanghai Henlius Biotech, Inc. - H Shares stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €3.9bn. The latest transaction was reported on 3 September 2026 (Other). Among the most active insiders: Zhu Jun. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Shanghai Henlius Biotech, Inc. is a China-based biopharmaceutical company focused on the development of biosimilar drugs. It specializes in the research and commercialization of treatments for cancer and other serious diseases.